Insider · CIK 0001622268

dEsparbes Eric

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001622268

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-08-15	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−27.8K sh	$0.67	−$18.6K	575,832
2024-02-15	BIORA THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+325K sh	—	—	603,662
2023-08-15	BIORA THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+220K sh	—	—	278,662
2023-08-15	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−40K sh	$3.14	−$126K	59,012
2023-05-15	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−2,807 sh	$3.35	−$9,403.45	99,034
2023-03-15	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−11.2K sh	$2.56	−$28.7K	101,841
2023-03-15	BIORA THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+62.2K sh	—	—	90,365
2023-03-15	BIORA THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+22.7K sh	—	—	113,057
2023-02-15	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−269 sh	$3.46	−$930.74	28,140
2023-01-03	BIORA THERAPEUTICS, INC.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−95 sh	—	—	0
2022-11-15	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−5,194 sh	$0.27	−$1,402.38	710,122
2022-08-15	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−5,952 sh	$1.04	−$6,190.08	708,429
2022-05-15	BIORA THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+292K sh	—	—	705,190
2022-05-15	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−10.4K sh	$0.75	−$7,790.25	412,784
2022-05-15	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+472K sh	—	—	472,495
2022-04-15	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+375K sh	—	—	375,032
2022-04-15	BIORA THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+232K sh	—	—	423,171
2022-02-15	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−4,919 sh	$1.90	−$9,346.1	191,478
2021-08-15	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−5,718 sh	$1.66	−$9,491.88	196,397
2021-04-15	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+176K sh	—	—	175,790
2021-04-15	BIORA THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+123K sh	—	—	215,805
2021-04-15	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−13.7K sh	$3.41	−$46.7K	202,115
2021-03-15	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+68K sh	—	—	67,953
2021-03-04	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−1,608 sh	$4.05	−$6,512.4	92,423
2021-02-15	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−5,361 sh	$5.60	−$30K	94,031
2020-12-19	BIORA THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−1,228 sh	$6.32	−$7,760.96	99,392
2020-08-15	BIORA THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+36.2K sh	—	—	100,620
2020-08-15	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+73.9K sh	—	—	73,863
2019-06-15	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+28.4K sh	—	—	28,406
2018-05-21	INVAInnoviva, Inc.S Sale	SVP and CFO	SSale	−5,808 sh	$14.40	−$83.6K	373,081
2018-05-20	INVAInnoviva, Inc.F Tax Payment	SVP and CFO	FTax Payment	−7,901 sh	$14.59	−$115K	376,965
2018-03-02	INVAInnoviva, Inc.A Award	SVP and CFO	AAward	+93.1K sh	—	—	384,866
2018-02-21	INVAInnoviva, Inc.S Sale	SVP and CFO	SSale	−5,378 sh	$16.52	−$88.8K	291,810
2018-02-20	INVAInnoviva, Inc.F Tax Payment	SVP and CFO	FTax Payment	−24.9K sh	$16.44	−$409K	297,188
2017-11-21	INVAInnoviva, Inc.S Sale	SVP and CFO	SSale	−13.5K sh	$13.31	−$179K	321,742
2017-11-20	INVAInnoviva, Inc.F Tax Payment	SVP and CFO	FTax Payment	−6,141 sh	$13.17	−$80.9K	337,027
2017-11-20	INVAInnoviva, Inc.S Sale	SVP and CFO	SSale	−1,825 sh	$13.04	−$23.8K	335,202
2017-08-21	INVAInnoviva, Inc.S Sale	SVP and CFO	SSale	−1,825 sh	$12.20	−$22.3K	343,168
2017-08-20	INVAInnoviva, Inc.F Tax Payment	SVP and CFO	FTax Payment	−5,770 sh	$12.28	−$70.9K	344,993
2017-05-22	INVAInnoviva, Inc.S Sale	SVP and CFO	SSale	−1,825 sh	$11.85	−$21.6K	350,763
2017-05-20	INVAInnoviva, Inc.F Tax Payment	SVP and CFO	FTax Payment	−4,208 sh	$11.86	−$49.9K	352,588
2017-02-21	INVAInnoviva, Inc.S Sale	SVP and CFO	SSale	−1,825 sh	$12.07	−$22K	354,296
2017-02-20	INVAInnoviva, Inc.F Tax Payment	SVP and CFO	FTax Payment	−8,604 sh	$12.04	−$104K	356,121
2017-01-17	INVAInnoviva, Inc.A Award	SVP and CFO	AAward	+133K sh	—	—	364,725
2016-11-21	INVAInnoviva, Inc.S Sale	SVP and CFO	SSale	−1,800 sh	$10.89	−$19.6K	231,327
2016-11-20	INVAInnoviva, Inc.F Tax Payment	SVP and CFO	FTax Payment	−3,832 sh	$10.91	−$41.8K	233,127
2016-08-22	INVAInnoviva, Inc.S Sale	SVP and CFO	SSale	−3,700 sh	$11.77	−$43.5K	236,193
2016-08-20	INVAInnoviva, Inc.F Tax Payment	SVP and CFO	FTax Payment	−2,845 sh	$11.79	−$33.5K	239,893
2016-05-20	INVAInnoviva, Inc.F Tax Payment	SVP and CFO	FTax Payment	−2,818 sh	$11.09	−$31.3K	242,738
2016-02-19	INVAInnoviva, Inc.F Tax Payment	SVP and CFO	FTax Payment	−5,457 sh	$12.28	−$67K	243,056

Recent filings

Accepted (ET)
Aug 164
dEsparbes Eric0000950170-24-098046
SEC(opens sec.gov)
Feb 154
dEsparbes Eric0000950170-24-015862
SEC(opens sec.gov)
Aug 174
dEsparbes Eric0000950170-23-043225
SEC(opens sec.gov)
May 174
dEsparbes Eric0000950170-23-022773
SEC(opens sec.gov)
Mar 174
dEsparbes Eric0000899243-23-009032
SEC(opens sec.gov)
Feb 174
dEsparbes Eric0000899243-23-005465
SEC(opens sec.gov)
Jan 54
dEsparbes Eric0000899243-23-000958
SEC(opens sec.gov)
Nov 164
dEsparbes Eric0000899243-22-036077
SEC(opens sec.gov)
Aug 164
dEsparbes Eric0000899243-22-028839
SEC(opens sec.gov)
May 174
dEsparbes Eric0000899243-22-018428
SEC(opens sec.gov)
Apr 194
dEsparbes Eric0000899243-22-015063
SEC(opens sec.gov)
Feb 174
dEsparbes Eric0000899243-22-006785
SEC(opens sec.gov)
Aug 174
dEsparbes Eric0000899243-21-033252
SEC(opens sec.gov)
Apr 194
dEsparbes Eric0000899243-21-016315
SEC(opens sec.gov)

Companies

Address

THERAVANCE, INC. 951 GATEWAY BLVD.

SOUTH SAN FRANCISCO, CA, 94080